The COVID-19 pandemic has harmed the provision of palliative care (PC) services for women with breast cancer due to all the restrictions that came along with the virus.
Objective:
To map the available evidence on the situation of PC in breast cancer during the COVID-19 pandemic.
Methods:
A scoping review was carried out based on the methodology proposed by the Joanna Briggs Institute. The search was conducted in nine databases, one electronic repository, and one library, using controlled vocabularies.
Results:
Twenty-nine articles and seven documents were included. The majority (11.4% each) were published in the United Kingdom, Italy, and the United States, 38.9% addressed palliative radiotherapy (RT), and 47.2% consisted of recommendations. From the content analysis, five categories were obtained focused on the recommendations on changes in palliative treatment guidelines and the response of PC teams to the evolving crisis.
Conclusions:
The evidence pointed to the management of general PC, palliative RT, palliative chemotherapy, management of metastatic breast cancer, and use of technologies in palliative care. No recommendations were found to manage frequent symptoms in PC, indicating the need to develop primary studies that investigate these aspects in detail in this vulnerable group.
Implications:
The results contained in this document can provide professionals working in this field of care with a global view of how other teams have dealt with the pandemic, thereby identifying the best guidelines to apply in their reality, taking into account the clinical and social situation of each patient.
The Lancet. Palliative care and the COVID-19 pandemic. Lancet. 2020;395(10231):1168. doi:10.1016/S0140-6736(20)30822-9
4.
RadbruchLKnaulFMde LimaLde JoncheereCBhadeliaA. The key role of palliative care in response to the COVID-19 tsunami of suffering. Lancet. 2020;395(10235):1467-1469. doi:10.1016/S0140-6736(20)30964-8
5.
AddaiBWNgwaW. COVID-19 and cancer in Africa. Science. 2021;371(6524):25–27. doi:10.1126/science.abd1016
6.
ChanJJSimYOwSGW, et al.The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience. Endocr Relat Cancer. 2020;27(9):R307-R327. doi:10.1530/ERC-20-0157
7.
WaksAGWinerEP. Breast cancer treatment: a review. JAMA. 2019;321(3):288-300. doi:10.1001/jama.2018.19323
Shinan-AltmanSLevkovichITavoriG. Healthcare utilization among breast cancer patients during the COVID-19 outbreak. Palliat Support Care. 2020;18(4):385-391. doi:10.1017/S1478951520000516
10.
FlorêncioRSCestariVRFde SouzaLC, et al.Palliative care amidst the COVID-19 pandemic: challenges and contributions. Acta Paul Enferm. 2020;33:eAPE20200188. doi:10.37689/acta-ape/2020AO01886
11.
ConnollyMBellMLawlerFTimminsFRyderM. Hospital-based palliative and end-of-life care in the COVID-19 pandemic: a scoping review. Am J Hosp Palliat Care. Published online December 11, 2021. doi:10.1177/10499091211057049
TriccoACLillieEZarinW, et al.PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467-473. doi:10.7326/M18-0850
14.
PageMJMoherDBossuytPM, et al.PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi:10.1136/bmj.n160
Pan American Health Organization. Folha informativa sobre COVID-19 - OPAS/OMS [COVID-19 fact sheet – PAHO/WHO]. Published 2021. Accessed October 8, 2021. https://www.paho.org/pt/covid19
18.
BotelhoRGda Cruz de OliveiraC. Literaturas branca e cinzenta: uma revisão conceitual. Ciência Informação. 2015;44(3):501-513. Accessed August 19, 2021. http://revista.ibict.br/ciinf/article/view/1804
19.
OuzzaniMHammadyHFedorowiczZElmagarmidA. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi:10.1186/s13643-016-0384-4
20.
ArmstrongRHallBJDoyleJWatersE. ‘Scoping the scope’ of a cochrane review. J Publ Health. 2011;33(1):147-150. doi:10.1093/pubmed/fdr015
21.
ValaitisRMartin-MisenerRWongST, et al.Methods, strategies and technologies used to conduct a scoping literature review of collaboration between primary care and public health. Prim Health Care Res Dev. 2012;13(3):219-236. doi:10.1017/S1463423611000594
22.
ShahiFMirzaniaMAghiliM, et al.Modifications in breast cancer guidelines in COVID-19 pandemic; an Iranian Consensus. Arch Breast Cancer. 2020;22:14-21. doi:10.32768/abc.20207114-21
PotenzaLLuppiMEfficaceFBrueraEBandieriE. COVID-19 pandemic and cancer: the importance of early palliative care. Oncologist. 2020;26(11):e2094-e2096. doi:10.1002/onco.13587
MartinMGuerrero‐ZotanoAMonteroÁ, et al.GEICAM guidelines for the management of patients with breast cancer during the COVID‐19 pandemic in Spain. Oncologist. 2020;25(9):e1339-e1345. doi:10.1634/theoncologist.2020-0363
GomesSSilvaDSáJ, et al.Predictors of home death and the quality of end-of-life care at a cancer center in Brazil. J Clin Oncol. 2021;39(suppl 15):e24004-e24004. doi:10.1200/JCO.2021.39.15_suppl.e24004
30.
SantiagoFBda SilvaALA. Primeiro caso de COVID-19 em uma unidade de Cuidados Paliativos oncológicos: relato de experiência. Enfermagem em Foco. 2020;11(2,n.esp):212-218. doi:10.21675/2357-707X.2020.v11.n2.ESP.3847
31.
BartmannCFischerLMHübnerT, et al.The effects of the COVID-19 pandemic on psychological stress in breast cancer patients. BMC Cancer. 2021;21(1):1356. doi:10.1186/s12885-021-09012-y
32.
BattistiNMLMislangARCooperL, et al.Adapting care for older cancer patients during the COVID-19 pandemic: recommendations from the international society of geriatric oncology (SIOG) COVID-19 working group. J Geriat Oncol. 2020;11(8):1190-1198. doi:10.1016/j.jgo.2020.07.008
33.
MoujaessEKourieHRGhosnM. Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence. Crit Rev Oncol-Hematol. 2020;150:102972. doi:10.1016/j.critrevonc.2020.102972
34.
ElghazawyHBakkachJZaghloulMS, et al.Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic. Future Oncol. 2020;16(31):2551-2567. doi:10.2217/fon-2020-0574
35.
IsmailiNEl MajjaouiS. Management of breast cancer during COVID-19 pandemic in Morocco. Breast J. 2020;26(8):1618-1619. doi:10.1111/tbj.13925
36.
JacobsonGKaidar-PersonOHaisraelyO, et al.Palliative radiation therapy for symptomatic advance breast cancer. Sci Rep. 2021;11(1):5282. doi:10.1038/s41598-021-84872-9
37.
VialeGLicataLSicaL, et al.Personalized risk–benefit ratio adaptation of breast cancer care at the epicenter of COVID‐19 outbreak. Oncologist. 2020;25(7):e1013-e1020. doi:10.1634/theoncologist.2020-0316
38.
DietzJRMoranMSIsakoffSJ, et al.Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020;181(3):487-497. doi:10.1007/s10549-020-05644-z
39.
CuriglianoGCardosoMJPoortmansP, et al.Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast. 2020;52:8-16. doi:10.1016/j.breast.2020.04.006
40.
CardosoFFCuriglianoG. Treating breast cancer during COVID-19: “indispensable.” medscape nurses. Published August 6, 2020. Accessed January 28, 2022. http://www.medscape.com/viewarticle/934667
41.
LombeDCMwabaCKMsadabweSC, et al.Zambia’s National cancer centre response to the COVID-19 pandemic—an opportunity for improved care. Ecancermedicalscience. 2020;14:1051. doi:10.3332/ecancer.2020.1051
42.
LinDDMeghalTMurthyP, et al.Chemotherapy treatment modifications during the COVID-19 outbreak at a community cancer center in New York City. JCO Glob Oncol. 2020;6:1298-1305. doi:10.1200/GO.20.00309
43.
VanniGSantoriFPellicciaroM, et al.Extremely advanced breast cancer presentation: possible effect of coronavirus pandemic anxiety. In Vivo. 2021;35(4):2331-2335. doi:10.21873/invivo.12508
44.
CastilloCCamejoNAmarilloD, et al.Impact of the COVID-19 pandemic on health care activities at a Uruguayan mastology teaching unit: Preliminary results. J Clin Oncol. 2021;39(suppl 15):e12502-e12502. doi:10.1200/JCO.2021.39.15_suppl.e12502
45.
TashkandiEAl-AbdulwahabABasulaimanB, et al.Mortality and morbidity of curative and palliative anticancer treatments during the COVID-19 pandemic: a multicenter population-based retrospective study. Mol Clin Oncol. 2021;14(4):1-11. doi:10.3892/mco.2021.2244
46.
BatraAMehtaPPatelA, et al.Breast cancer treatment during the COVID-19 Pandemic. Indian J Med Paediatr Oncol. 2021;41(2):135-137. doi:10.4103/ijmpo.ijmpo_111_20
ShengJYSanta-MariaCAManginiN, et al.Management of breast cancer during the COVID-19 pandemic: a stage- and subtype-specific approach. JCO Oncol Pract. 2020;16(10):665-674. doi:10.1200/OP.20.00364
MayaFHMayaRBHincapié UribeAL, et al.Recomendaciones para el diagnóstico, tratamiento y seguimiento del cáncer de mama durante la pandemia de SARS-Cov-2/COVID-19 en Colombia. Rev Colomb Cancero. 2020;24:252-257. doi:10.35509/01239015.687
51.
CamejoNCastilloCArtagaveytiaN, et al.Evaluation of the effectiveness of telephone consultations and the level of satisfaction of patients attending the Unidad Docente Asistencial de Mastología [Mastology Care Teaching Unit] using this method during the COVID health emergency. J Clin Oncol. 2021;39(suppl 15):e13610-e13610. doi:10.1200/JCO.2021.39.15_suppl.e13610
52.
LewinWMarchingtonKZimmermannC. Primary care communication and palliative care in the era of COVID-19. Can Fam Physician. Published July 9, 2020. Accessed January 28, 2022. https://www.cfp.ca/news/2020/07/09/07-10
53.
SilvaMPPSunemiMMdOFrettaTdB, et al.Recomendações para Fisioterapia em Oncologia Mamária e Ginecológica durante a Pandemia de COVID-19: revisão da Literatura. Rev Bras Cancerol. 2021;67(2):e191510. doi:10.32635/2176-9745.RBC.2021v67n2.1510
54.
StockdillMLBarnettMDTaylorRADionne-OdomJNBakitasM. Telehealth in palliative care: communication strategies from the COVID-19 pandemic. Clin J Oncol Nurs. 2021;25(1):17-22. doi:10.1188/21.CJON.17-22
55.
ArifTShamim AbsarMMoughanB. The American society of breast surgeons official proceedings, volume XXII 2021 annual meeting scientific session abstracts. Ann Surg Oncol. 2021;28:163-400. doi:10.1245/s10434-021-10068-0
56.
McGrowderDAMillerFGVazK, et al.The utilization and benefits of telehealth services by health care professionals managing breast cancer patients during the COVID-19 pandemic. Healthcare. 2021;9(10):1401. doi:10.3390/healthcare9101401
57.
LutzSTJonesJChowE. Role of radiation therapy in palliative care of the patient with cancer. J Clin Orthod. 2014;32(26):2913-2919. doi:10.1200/JCO.2014.55.1143
58.
ColesCEAristeiCBlissJ, et al.International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic. Clin Oncol. 2020;32(5):279-281. doi:10.1016/j.clon.2020.03.006
59.
HazinRQaddoumiI. Teleoncology: current and future applications for improving cancer care globally. Lancet Oncol. 2010;11(2):204-210. doi:10.1016/S1470-2045(09)70288-8
60.
TashkandiEZeeneldinAAlAbdulwahabA, et al.Virtual management of patients with cancer during the COVID-19 pandemic: web-based questionnaire study. J Med Internet Res. 2020;22(6):e19691. doi:10.2196/19691
61.
da SilvaAPSAlexandreHGde AlmeidaPCXimenesLBFernandesAFC. Effects of an educational technology application in the early detection of breast cancer. Rev Rene. 2017;18(3):404-411. doi:10.15253/2175-6783.2017000300017
62.
HensonLAMaddocksMEvansCDavidsonMHicksSHigginsonIJ. Palliative care and the management of common distressing symptoms in advanced cancer: pain, breathlessness, nausea and vomiting, and fatigue. J Clin Oncol. 2020;38(9):905-914. doi:10.1200/JCO.19.00470
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
